DAIC

JULY 29, 2024

Edwards has entered into an agreement to acquire JenaValve Technology , a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is largely untreated today. A CMS national coverage determination is expected in early 2025. billion.

Innovation 98

Innovation Aortic valve Aortic CMS 98

DAIC

JULY 15, 2024

Getty Images mtaschetta-millane Mon, 07/15/2024 - 11:06 July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd. , Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025.

Bicuspid/Mitral 105

Bicuspid/Mitral Tricuspid Technology Innovation 105

DAIC

MARCH 18, 2024

a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System.

Innovation 105

Innovation Bicuspid/Mitral Exercise Technology 105